4 ms·
Do we really know what the current capabilities are. It would be top secret. It's been decades of research. I would expect many of these issues have been worked
by dukeofdoom 3y ago
Do we really know what the current capabilities are. It would be top secret. It's been decades of research. I would expect many of these issues have been worked around.
I used to think AI was fictional pipe dream. Yet it came to be.
> 1. It's difficult to manufacture biological agents in large quantities.
Yet the covid vaccine was manufactured in huge quantities in short time.
> 2. It's hard to store biological agents for long periods of time, since living things tend to die.
The covid vaccine was kept cold storage of -60, and it was good for 18 months.
>3. It's hard to disperse biological agents over a large area.
This would not be an issue for a respiratory virus, that targets a specific ethnic group.
> 4. It's easy to protect troops in the field from biological agents and all major countries maintain and exercise the capability to do so.
Yet almost everyone got infected by covid.
> 5. Biological agents are slow acting and unreliable in their effect.
Covid was fast acting. Yet not that deadly. So i suppose if it was more deadly this too would fall.
- morkalork 3y agoThe problem with #3 is that viruses will happily evolve and hop species. Covid for example spread to farmed mink, then to wild populations. Even random zoo animals were catching it.
- rurban 3y agoWe do have the results of the South African chemical and biological weapons program in clear: https://css.ethz.ch/en/services/digital-library/articles/article.html/d6264a52-9fba-4986-baa2-cf30c2bddc1a#Doc90 https://css.ethz.ch/en/services/digital-library/articles/art... And they certainly did not come out with such lists out of the blue.
- sterlind 3y agotargeting a specific ethnic group would be extremely challenging. afaik, ethnicity is actually responsible for surprisingly little genetic variation. maybe you could e.g. come up with a spike protein that's 25% better at binding an ACE2 receptor variant that 80% of ethnic group X has vs. only 30% of ethnic group Y, but that's not going to make Y immune.